Loading

Journal of Chronic Diseases and Management

Unloading Mechanical Ventilation (VUMV) with High Volume, no PEEP and little Sedation for patients with ARDS and COVID19

Review Article | Open Access Volume 6 | Issue 1 |

  • 1. Clinic for Cardiology and Pneumology, University Medical Center Göttingen (UMG), Germany
+ Show More - Show Less
Corresponding Authors
Gerhard Laier-Groeneveld; Clinic for Cardiology and Pneumology, University Medical Center Göttingen (UMG), Lungenklinik Neustadt Harz Badestrasse 23,D99768 Neustadt Harz, Germany, Tel: 01725609808; Email: laier-groeneveld@t-online.de
Abstract

ARDS, a syndrome of various diseases with severe hypoxemia including COVID-19, is treated with low volumes, high PEEP and low pressure. Mortality is high with 30 to 50% and up to 80% during the SARS COV2 pandemia. A different strategy, to relief dyspnea with a high tidal volume, low PEEP to overventilate the patients and put their overloaded muscles at rest results in much lower mortality rates from 2 to 8%. However patients in these series might be different and randomized studies lack. In addition, actual ventilators favour the lung protective strategy, as they are underpowered to effectively support the respiratory muscles.

In addition to a randomized study comparing the unloading strategy to the lung protective, which is on the way, we designed a ventilator to meet this unloading strategy in that it automatically keeps the patient passively ventilated.

Keywords

Mechanical Ventilation, Sedation, High tidal volume, PEEP

Citation

Laier-Groeneveld G (2022) Unloading Mechanical Ventilation (VUMV) with High Volume, no PEEP and little Sedation for patients with ARDS and COVID19. J Chronic Dis Manag 6(1): 1027.

INTRODUCTION

Acute Respiratory Distress Syndrome ARDS comprises a number of different diseases, which have in common a severe hypoxemia, defined as arterial oxygen pressure over inspiratory fraction of oxygen pO2/FiO2 < 300. COVID-19 although new, is also considered as ARDS, so called CARDS.

There are numerous guidelines for the treatment of ARDS and thus COVID19 CARDS, which focus on early intubation and lung protective ventilation with prone positioning. However, many patients then die shortly after intubation and during the following treatment. Since years, and again with COVID19 disease, we offer an alternative strategy to save their lives and to spare the resources needed to treat numerous patients at the same time.

We observe two manifestations of COVID19. One is acute pneumonia with minor or no changes in chest CT scan. This disposes to acute exacerbations of chronic lung diseases and does not perform differently to exacerbations caused by other organisms outside of SARS-COV-2 pandemic. Medical treatment, oxygen and noninvasive ventilation are the standard therapy.

More threatening is COVID19 pneumonia with cellular patchy infiltrates throughout the lungs and progressive and considerable hypoxemia. We avoid to intubate such patients and treat them with high dose oxygen, high flow oxygen and noninvasive ventilatory unloading ventilation (nMUMV) to ventilate them passively and relief them from dyspnea. Only in case of cerebral confusion due to in compensable hypoxemia, we perform wakeful intubation and ventilatory unloading mechanical ventilation VUMV to completely unload the ventilatory pump. Once intubated, we use a high volume and wean them to spontaneous breathing or to noninvasive ventilation at the earliest possible time. This treatment is discussed below.

As Oxygen and CO2 are vital gases, a lack of oxygen and an increase in pCO2 are subjectively well tolerated by humans after adaptation was possible. They climb high mountains with considerably low pO2 down to 30mmHg and saturations down to 60%. In healthy individuals oxygen content is 21ml per 100ml of blood before and 18ml after extraction in the capillary bed leaving huge compensation in place for hypoxemia. In addition, oxygen delivery is more dependent on cardiac minute volume and haemoglobin than on saturation or pO2.

In consequence in COVID19 patients spontaneous breathing can be preserved up to very low pO2 pressures as long as they are not confused and cerebral and renal function remain intact. This avoids the threat of invasive mechanical ventilation to their lives.

We observe patients with severe hypoxemia due to multiple patchy pulmonary infiltrates caused by COVID19, who remain mentally adequate and improved within days from their disease. They use oxygen, high flow oxygen and noninvasive mechanical ventilation over masks but eat and drink and cough in their short periods off the machine. We therefore do not intubate until cerebral organ failure occurs and the vast majority is not intubated at any time.

Intubation in such situation is critical. If sedatives are given in order to intubate, they instantly deteriorate in saturation and mechanical ventilation must abruptly take over complete ventilation. As patients are already mentally compromised minimal or no sedatives are necessary until the tube is in place. This avoids rapid desaturation when their respiratory efforts abruptly cease following full sedation. Mechanical ventilation should augment patient´s respiration immediately after intubation with a high ventilatory rate, short inspiratory time and a high tidal volume. Sedation should be introduced carefully to smoothen the transfer from spontaneous to mechanical ventilation and to carefully install ventilatory unloading mechanical ventilation (VUMV) to relief their dyspnea. If not patients severely deteriorate in gas exchange, develop profound acidosis and die from acute ventilatory failure as reported in many intubated COVID19 patients.

If then mechanical ventilation is inevitable, the ventilatory strategy must be determined. Two mutually exclusive ventilatory strategies are used:

• The lung protective strategy is performed with a low tidal volume, usually 6ml per kg of ideal body weight, with a ventilation pressure below 30mbar, and a high PEEP. The increase in pO2 is the target of this strategy

• The ventilatory unloading strategy of mechanical ventilation (VUMV) uses much higher tidal volumes and sufficiently high inspiratory pressures to drive the arterial pCO2 below 40mmHg together with little or no PEEP. It is set to unload the ventilatory pump and to improve spontaneous breathing capacity by improving ventilatory function. This is the strategy we propose.

The lung protective strategy of mechanical ventilation was introduced in times when large fluid volumes were given in response to a low blood pressure called fluid resuscitation. Fluid increases tissue pressure in the lung and can cause airway closure by dissemination of fluid into the alveoli. Fluid is responsible to PEEP and changing body position to increase pO2 but also to diuretics. It was assumed that ventilation causes trauma to the lung followed by progressive lung failure. The thesis has mainly been investigated in ARDS syndrome with an excessive fluid congested lung [1,2]. During expiration the alveoli were assumed to collapse due to the interstitial fluid load. Each mechanically initiated breath then requires a high reopening pressure, which causes stress to the lung tissue named stretch and strain. A high PEEP is set as it does not allow the airways to close. A low tidal volume together with low inspiration pressure are intended to prevent barotrauma and protect the lung from damage. However, by scientific evidence, volume resuscitation strategy has changed to volume deresuscitation and cellular infiltrates as in COVID19 do not respond to PEEP or changes in body position. We therefore do not use this strategy in COVID19, neither the lung protective strategy or PEEP nor prone positioning of the patient. They require huge sedation sometimes relaxation to be tolerated followed by a high mortality from hypotensive ventilatory failure.

The ventilator unloading strategy, which we prefer in COVID19, treats the overloaded ventilatory muscles and relieves failure of the ventilatory pump and by this respiratory distress. It has been established in neuromuscular disorders where the lungs are not affected and only the muscles are weak and overloaded. Ventilatory unloading results in a normal pCO2 during ventilation, a normal pCO2 during spontaneous breathing, in improved breathing capacity, in an increase in quality of life and in longevity. Most evidence exists in COPD. The load is high, to overcome intrinsic PEEP and to provide an increased tidal volume. The inspiratory pressure reserve is decreased by severe lung hyperinflation and by shortening of the inspiratory muscles [3]. In a multicentre study we could demonstrate a mortality reduction from 33% to 12% in initially hypercapnic COPD per year [4-6] (Figure 1-3).

The lung protective and ventilatory unloading strategy of mechanical ventilation are completely opposite. Before to start with mechanical ventilation the  strategy has to be determined. We porpose a ventilatory unloading startegy in all patients with COVID19. It shows the pressure time curves of a mechanical ventilated  patient in a volume preset mode of ventilation. Below the apnoea threshold (above) with a totally passive ventilation to avoid any need for sedatives. There are no patients  efforts. Little above the apnoea threshold (below) irregular ventilatory efforts of the patient interfere with ventilation. Dyspnoea increases and requires sedatives to  tolerate as soon as a critical threshold is reached or when asynchrony occurs.

Figure 1: The lung protective and ventilatory unloading strategy of mechanical ventilation are completely opposite. Before to start with mechanical ventilation the strategy has to be determined. We porpose a ventilatory unloading startegy in all patients with COVID19. It shows the pressure time curves of a mechanical ventilated patient in a volume preset mode of ventilation. Below the apnoea threshold (above) with a totally passive ventilation to avoid any need for sedatives. There are no patients efforts. Little above the apnoea threshold (below) irregular ventilatory efforts of the patient interfere with ventilation. Dyspnoea increases and requires sedatives to tolerate as soon as a critical threshold is reached or when asynchrony occurs.

The ventilator mode and setting we used in our COVID19 patients.

Figure 2: The ventilator mode and setting we used in our COVID19 patients.

The proposed strategy in COVID19.

Figure 3: The proposed strategy in COVID19.

Patients, suffering from COVID19, are dyspnoeic and severely hypoxic. Mechanical ventilation can unload the respiratory muscles completely, relieve their dyspnoea and decrease the pCO2 to normal. This occurs because the elimination of CO2 is only dependent on alveolar ventilation. The diffusion capacity of CO2 is 20fold higher compared to oxygen and its solubility in fluid is 25fold better. Therefore, in reality the transport of CO2 within the blood from the tissue to the lung and the diffusion of CO2 from the blood into the alveoli is not a limitation as long as blood circulation is active. The arterial pCO2, while breathing spontaneously, only depends on the alveolar ventilation provided by the respiratory muscles. During mechanical ventilation, pCO2 is a consequence of the decision of the therapist, as he sets the ventilator and determines alveolar ventilation. In conclusion, hypercapnia is not a consequence of lung disease but a result of ventilatory pump failure. Any increase in alveolar ventilation will result in a decrease of arterial pCO2. Every patient can be ventilated to a normal pCO2, both by invasive and non-invasive means [3]. Dyspnea is dependent on the action of the respiratory muscles. If the patient does not breathe, he does not experience dyspnea. Dyspnea is highly related to the patient´s effort to breathe (Criee). There is an apnoea threshold, usually more than 4 mmHg below the patient´s pCO2 [5]. He then stops to breath when mechanically hyperventilated as soon as this threshold is reached. We extensively reported the technique of ventilatory unloading, the ventilators used and how the modes are set in Chapter 2 in Esquinas: Mechanical ventilation.

Oxygen by contrast is largely present in ambient air (21%) and can be further augmented by oxygen supplementation to the inspiratory air. Oxygen supply is therefore not limited by the ventilation of the lung. Oxygen has a 25 fold lower diffusing capacity than CO2 through the alveoli blood barrier. Impairment of diffusion will always interfere with oxygen uptake. Haemoglobin packed in red cells is required to make oxygen transport to tissue possible, as solubility in fluid is minimal. In summary, oxygen supply in contrast to CO2 removal is largely dependent on diffusion and ventilation perfusion match in the lung as well as on the transport capacity (minute volume and haemoglobin) of the blood. Hypoxemia therefore can be treated with oxygen and high flow oxygen. But thereafter hypoxemia has to be tolerated until relief. Only complains as dyspnea can be treated by VUMV noninvasively or invasively until disease resolves.

Preference of a ventilatory strategy: As described above, prevention of airway collapse and tissue stress during instant reopening is the pathophysiological rationale for lung protective ventilation. In real life, however, this phenomena rarely occurs. Of course, if tissue pressure is high, which is the case in highly over floated lungs due to left heart failure or other capillary leak syndrome (ARDS), such alveolar collapse can occur. High dose diuretics and short time CPAP as needed or pressure support can often rapidly correct this phenomena in cardiac lung edema.

A considerable proportion of patients with ventilatory failure suffer from COPD. COPD is characterized by airway obstruction. The airways usually close before full expiration has occurred, providing an increased end expiratory alveolar volume called volumen pulmonum auctum or increased end expiratory pressure, intrinsic PEEP. With either mechanism of intrinsic PEEP, airway closure before the end of expiration or the necessity to inspire before expiratory flow has ceased due to dyspnea the alveoli are kept open if not extended. The presence of emphysema with irreversible enlargement and destruction of the alveolar air space will also make a collapse of the alveoli impossible. All COPD therefore have to be excluded from lung protective ventilation due to a different pathophysiology without a risk of alveolar collapse. They instead suffer from extensive dyspnea due to a high load on the inspiratory muscles to overcome intrinsic PEEP. They struggle to provide the increased tidal volume, with their inspiratory muscles extensively shortened by emphysematous over inflation. Such ventilatory over load can, however, be fully addressed by the unloading strategy of mechanical ventilation. If the ventilator load is taken over by the respirator, the patient’s complaints will instantly disappear. This is a major reason for the success of non-invasive ventilation and its considerable benefit on mortality through this disease. Symptoms and ventilatory failure can be improved and hazardous effects of intubation, sedation and inactivity can be avoided. Not only COPD but all patients requiring mechanical ventilation experience an increased respiratory drive and an increased inspiratory load, making them candidates for the ventilator unloading strategy. No randomized comparison of the two strategies has been performed so far. We could show in 20 patients that a transfer from lung protection to ventilatory unload does not produce any negative effects but requires less sedatives, allows more spontaneous breathing, results in better cardiac stability and increased diuresis [7,8]. In a single case study a transfer from non-invasive ventilatory unload to invasive lung protection resulted in severe hypercapnia, severe acidosis, high sedative requirement, a fall in blood pressure with the consequence of catecholamine administration, fluid resuscitation and progressive renal failure [9]. This year we reported on a huge number of patients with different respiratory disorders. Guidelines still propose lung protective ventilation in several disorders. By contrast, we always use the unloading ventilatory strategy with any patient [10], and reserve the lung protective strategy for those who are severely overloaded with fluids and only until the diuresis is initiated.

The unloading ventilatory modes: Mechanical ventilation can increase the inspiratory tidal volume until the patient is totally ventilated by the machine. Once the apnoea threshold of CO2 is reached, spontaneous breathing efforts cease both with invasive ventilation and with non-invasive ventilation via masks. The apnoea threshold of the respiratory centre usually is reached at 4 mmHg below the spontaneous PCO2 in the normocapnic and up to 7mmHg below spontaneous pCO2 in the hypercapnic patient [10]. If the threshold is reached, respiratory drive decreases, ventilatory effort ceases and passive controlled mechanical ventilation is in place. This is why passive unloading mechanical ventilation is possible even without any sedatives. Patients with severe respiratory distress as during a life threatening asthma attack will also be ventilated comfortably beyond the apnoea threshold [11].

We treated 4 patients with the unloading strategy after they were treated with lung protective ventilation and prone positioning for 2 to 14 days. They were transferred from Alsace, France to our unit. PEEP was decreased to 4mbar which resulted in a significant increase in tidal volume. With a ventilator frequency near 18 per minute and an inspiratory time of 1.4 s and the elevation of ventilation pressure up to 35mbar and more a pCO2 below 35mmHg was obtained. FiO2 was tailored down to an Sa02 of 93%. Then sedatives were completely withdrawn as the patent was passively ventilated. Catecholamines could be reduced and withdrawn in 3 within the following hours. After a 30 min T piece trial patient one was extubated 20 hair after arrival. Patient 2 sustained the breathing trail but did not yet awake from long their sedation. Patient 3 and 4 are passively ventilated and perform twice daily breathing trials in preparation for Extubation. Up to now no one died (Table 1).

Table 1: Ventilation parameters and measurements upon arrival and after having changed the ventilatory strategy.

          Upon arrival         After having changed the settings
  mean SD mean SD
FiO2 0.44 0.13 0.35 0.1
PEEP (mbar) 11 2 2 2
Tidal volume (ml) 426 39 840 31
Inspiratory pressure (mbar) 16 1.5 31 2
pH 7.42 0.04 7.48 0.04
PaCO2 (mmHg) 45 9 34 2
SaO2 (%) 96 3 93 1
PaO2 /FiO2 195 35 205 28

Once intubated we use VUMV with no or little sedatives and perform T piece trial twice daily in order to extubate as early as possible either to spontaneous breathing or to intermittent noninvasive ventilation.

In summary we observe 2 manifestations of COVID19: Tracheobronchitis with the risk of COPD exacerbation and COVID19 pneumonia with progressive hypoxemia.

We manage them both symptomatically and with medical treatment of the diseases prevalent, especially COPD and fluid overload.

We avoid intubation until mental confusion makes intubation inevitable despite very severe hypoxemia. We use oxygen, high flow oxygen and early noninvasive VUMV until complaints improve.

A RANDOMIZED STUDY

A randomized study between these two strategies lung protection and ventilatory unload is urgently needed, to define the best strategy in different situations in order to decrease this unacceptable high mortality and to prevent such functional deterioration inevitably occurring with long term sedation.

A MECHANICAL VENTILATOR FOR THE VENTILATORY UNLOADING STRATEGY

Most existing ventilators support lung protection as pressures are limited and flow and pressure develop slowly, not to stress the lung. Thus, ventilatory support is difficult with these devices.

We develop new ventilators which in addition to the existing modes, are capable to overventilate the patient and automatically keep him overventilated below the apnea threshold. He then is comfortable and free of dyspnea with normal gases and normal acid base balance. Little or no sedatives are needed if he consistently remains passively ventilated. Therefore rapid detection of spontaneous breathing attempts and immediate response generated by a highly flow powered ventilator is needed. The concept has been developed and studied for years. COVID19 pandemic however has provided interest in such development. If there was no or only limited intensive care mortality in COVID-19, the whole strategy of SARS-COV-2 prevention would change.

PROPOSED TREATMENT STRATEGY IN COVID-19 VIRUS PNEUMONIA

If hypoxaemic (gas exchange failure)

Increase oxygen supply by nasal canula, by high flow heated oxygen and do not intubate unless mental dysfunction occurs

If dyspnoeic with high breathing frequency (ventilatory failure)

Use noninvasive ventilatory support for several hours with high tidal volume, low PEEP, low pCO2 to relieve dyspnoea, decrease breathing frequency and unload the ventilatory muscles. Avoid intubation and increase noninvasive support in time and intensity as needed.

 

ONLY INTUBATE, IF SUFFICIENT SUPPORT IS NO MORE TOLERATED AND PCO2 INCREASES

Continue invasive ventilation with high tidal volumes, little PEEP and low pCO2 to avoid or minimize sedation.

Transfer to tracheotomy to provide passive non sedated ventilation with periods of spontaneous breathing to await recovery. Keep cooperativity and activity perceived.

REFERENCES

1. The ARDS study. Ventilation with lower tidal volumes as compared with traditional tidal volume for acute lung ijury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342: 1301-1308.

2. Criée CP, Laier-Groeneveld G, Hüttemann U. Treatment of impaired respiratory muscle function. Atemwegs- Lungenkrkh. 1992; 18.

3. Laier-Groeneveld G, Gietl C, Bauer J. Normocapnia following noninvasive ventilation in aacute exacerbations and chronic state of obstructive pulmonary disease. J Physiol Pharmacol. 2007; 58: 339- 344.

4. Schucher B, Laier-Groeneveld G, Huettemann U, Criée CP. Effects of intermittent self-ventilation on ventilatory drive and respiratory pump failure. Med Klin (German). 1995; 90: 13-16.

5. Köhnlein T, Criée CP, Köhler D, Welte T, Laier-Groeneveld G, et al. Non -invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary diseae: A prospective multicentre, randomized, controlled, clinical trial. The Lancet Respiratory Medicine. 2014.

6. Murphy P, Rehal S, Arbane G, Bourke S, Calverly P, et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death after an Acute COPD Exacerbation: A Randomized Trial. JAMA; 2017; 317: 2177.

7. Mueller K, Laier-Groeneveld G, Alberts CH, Ryskus L. Lung protective ventilation versus ventilatory unloading ventilation - a direct comparison. Pneumologie (German). 2012.

8. Laier-Groeneveld G, Krause K, Abazed Y. Which ventilatory strategy: ventilatory unload or lung protection A case report. Pneumologie (German). 2017.

9. Schucher B, Laier-Groeneveld G, Hütteemann U, Criée CP. Effects of intermittent self ventilation on ventilatory drive and respiratory pump function. Med Klin. 1995; 90.

10.Laier-Groeneveld G, Alberts CH. Noninvasive intermittent ventilation in severe life threatening Asthma.Pneumologie (German). 2013.

11.Kaup-Wittemer D, N von Steinbuechel, Wasner M, Laier-Groeneveld G, Borasio G. Quality of life and psychological issues in ventilated patients with amyotrophic lateral sclerosis and theeir care givers. J Pain and Symptom Management. 2003; 26.

12.Othman F, Laier-Groeneveld G,Brinkmnn K, Toukmaktsi S. Atmungsentlastung ode Lungenprotektion - welches Beatmungsziel. Pneumologie (German) 2020, S1: S34.

13.Laier-Groeneveld G, Othman F, Toukmaktsi S, Wiemann J. Das Multiorganversagen könnte therapiebedingt sein. Pneumologie (German). 2020; S1: S35.

14.Koerber W, Laier-Groeneveld G, Criée CP. Problems with intermittent noninvasive ventilation. Atemwegs- Lungenkrkh.(German). 1997; 23.

Laier-Groeneveld G (2022) Unloading Mechanical Ventilation (VUMV) with High Volume, no PEEP and little Sedation for patients with ARDS and COVID19. J Chronic Dis Manag 6(1): 1027.

Received : 10 May 2022
Accepted : 14 Jun 2022
Published : 17 Jun 2022
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X